Molecular Pharmacology: 29 (3)

March 01, 1986; Volume 29,Issue 3

You have access
Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
S M Lanier, H J Hess, A Grodski, R M Graham and C J Homcy

Molecular Pharmacology March 1986, 29 (3) 219-227;
You have access
Effects of temperature and membrane phase transitions on ligand binding to alpha 2-receptors of human platelets.
M J Lohse, K N Klotz and U Schwabe

Molecular Pharmacology March 1986, 29 (3) 228-234;
You have access
Solubilization of [3H]leukotriene D4 receptor complex from guinea pig lung membranes.
S Mong, H L Wu, J M Stadel, M A Clark and S T Crooke

Molecular Pharmacology March 1986, 29 (3) 235-243;
You have access
Uncoupling of gamma-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: effect of N-ethylmaleimide on purified GTP-binding proteins.
T Asano and N Ogasawara

Molecular Pharmacology March 1986, 29 (3) 244-249;
You have access
Molecular mechanisms of the potent and stereospecific nicotinic receptor agonist (+)-anatoxin-a.
K L Swanson, C N Allen, R S Aronstam, H Rapoport and E X Albuquerque

Molecular Pharmacology March 1986, 29 (3) 250-257;
You have access
Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
Y Watanabe and K H Jakobs

Molecular Pharmacology March 1986, 29 (3) 258-263;
You have access
Modulation of calmodulin function and of Ca2+-induced smooth muscle contraction by the calmodulin antagonist, HT-74.
T Tanaka, H Umekawa, M Saitoh, T Ishikawa, T Shin, M Ito, H Itoh, Y Kawamatsu, H Sugihara and H Hidaka

Molecular Pharmacology March 1986, 29 (3) 264-269;
You have access
The effect of 16 beta-substitution on the structure and activity of digitoxigenin: is there an additional binding interaction with Na+,K+-ATPase?
J F Griffin, D C Rohrer, K Ahmed, A H From, T Hashimoto, H Rathore and D S Fullerton

Molecular Pharmacology March 1986, 29 (3) 270-274;
You have access
Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes.
B Gasnier, M P Roisin, D Scherman, S Coornaert, G Desplanches and J P Henry

Molecular Pharmacology March 1986, 29 (3) 275-280;
You have access
Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.
B Giros, C Gros, B Solhonne and J C Schwartz

Molecular Pharmacology March 1986, 29 (3) 281-287;
You have access
Effects of mercury (II) compounds on the activity of dUTPases from various sources.
M V Williams

Molecular Pharmacology March 1986, 29 (3) 288-292;
You have access
Effect of the polar head structure of polyene macrolide antifungal antibiotics on the mode of permeabilization of ergosterol- and cholesterol-containing lipidic vesicles studied by 31P-NMR.
B Cybulska, M Herve, E Borowski and C M Gary-Bobo

Molecular Pharmacology March 1986, 29 (3) 293-298;
You have access
Regional difference in brain benzodiazepine receptor carbohydrates.
P M Sweetnam and J F Tallman

Molecular Pharmacology March 1986, 29 (3) 299-306;
You have access
Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
A C Howlett, J M Qualy and L L Khachatrian

Molecular Pharmacology March 1986, 29 (3) 307-313;
You have access
Proposals for the mu-active conformation of the enkephalin analog Tyr-cyclol(-N gamma-D-A2-bu-Gly-Phe-Leu-).
B Maigret, M C Fournie-Zaluski, B Roques and S Premilat

Molecular Pharmacology March 1986, 29 (3) 314-320;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals